These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12061025)

  • 21. [Regression of hepatic fibrosis physiopathological aspects and clinical reality].
    Bédossa P; Paradis V
    Presse Med; 2003 Apr; 32(15):704-10. PubMed ID: 12754452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatic stellate cells and oxidative stress].
    Urtasun R; Nieto N
    Rev Esp Enferm Dig; 2007 Apr; 99(4):223-30. PubMed ID: 17590105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrogenesis in nonalcoholic steatohepatitis.
    De Minicis S; Svegliati-Baroni G
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):179-87. PubMed ID: 21476913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stellate cell activation in alcoholic fibrosis--an overview.
    Friedman SL
    Alcohol Clin Exp Res; 1999 May; 23(5):904-10. PubMed ID: 10371412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cells and hepatic cirrhosis.
    Chen Z; Qi LZ; Zeng R; Li HY; Dai LJ
    Panminerva Med; 2010 Jun; 52(2):149-65. PubMed ID: 20517197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic fibrosis, stellate cells, and portal hypertension.
    Rockey DC
    Clin Liver Dis; 2006 Aug; 10(3):459-79, vii-viii. PubMed ID: 17162223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of hepatic fibrosis and the role of cytokines.
    Lissoos TW; Davis BH
    J Clin Gastroenterol; 1992 Jul; 15(1):63-7. PubMed ID: 1500664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?
    Tu T; Calabro SR; Lee A; Maczurek AE; Budzinska MA; Warner FJ; McLennan SV; Shackel NA
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1696-704. PubMed ID: 26239824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro.
    Zhang Z; Guo Y; Zhang S; Zhang Y; Wang Y; Ni W; Kong D; Chen W; Zheng S
    Eur J Pharmacol; 2013 Dec; 721(1-3):133-40. PubMed ID: 24076327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Research progress of liver sinusoidal endothelial cells in the regulation of liver microenvironment to affect liver fibrosis].
    Deng XX; Li H; Zhang ZF; Gu QL
    Zhonghua Gan Zang Bing Za Zhi; 2020 Apr; 28(4):357-360. PubMed ID: 32403890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice.
    Osawa Y; Seki E; Adachi M; Suetsugu A; Ito H; Moriwaki H; Seishima M; Nagaki M
    Hepatology; 2010 Jan; 51(1):237-45. PubMed ID: 19821528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic fibrogenesis.
    Guo J; Friedman SL
    Semin Liver Dis; 2007 Nov; 27(4):413-26. PubMed ID: 17979077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biochemical markers of fibrogenesis in liver diseases].
    Szántová M; Kupcová V
    Bratisl Lek Listy; 1999 Jan; 100(1):28-35. PubMed ID: 10492995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fibrogenesis and liver transplantation].
    Benlloch S; Beltrán B; Moreno R; Berenguer M
    Gastroenterol Hepatol; 2003; 26(6):381-95. PubMed ID: 12809575
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent.
    Chouteau P; Defer N; Florimond A; Caldéraro J; Higgs M; Gaudin A; Mérour E; Dhumeaux D; Lerat H; Pawlotsky JM
    J Hepatol; 2012 Sep; 57(3):499-507. PubMed ID: 22613003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells regulate angiogenesis associated with liver fibrogenesis.
    Blois SM; Piccioni F; Freitag N; Tirado-González I; Moschansky P; Lloyd R; Hensel-Wiegel K; Rose M; Garcia MG; Alaniz LD; Mazzolini G
    Angiogenesis; 2014 Jan; 17(1):119-28. PubMed ID: 24068342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrosis in the liver: acute protection and chronic disease.
    Lee Y; Friedman SL
    Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial hepatectomy-induced regeneration accelerates reversion of liver fibrosis involving participation of hepatic stellate cells.
    Suárez-Cuenca JA; Chagoya de Sánchez V; Aranda-Fraustro A; Sánchez-Sevilla L; Martínez-Pérez L; Hernández-Muñoz R
    Exp Biol Med (Maywood); 2008 Jul; 233(7):827-39. PubMed ID: 18445764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic stellate cells and the reversal of fibrosis.
    Kisseleva T; Brenner DA
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Liver fibrosis: pathophysiology, diagnosis and treatment].
    Pár A; Pár G
    Orv Hetil; 2005 Jan; 146(1):3-13. PubMed ID: 15715367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.